Table 2.
Salvage RP characteristics and follow‐up details.
| Variable | Value |
|---|---|
| Number of patients, n (%) | 39 (100) |
| sRP approach, n (%) | |
| Laparoscopic | 3 (7.7) |
| Robot‐assisted | 36 (92.3) |
| Nerve‐sparing surgery, n (%) | |
| Unilateral | 10 (25.6) |
| Bilateral | 25 (64.1) |
| None | 3 (7.7) |
| NA | 1 (2.6) |
| Pelvic lymph node dissection, n (%) | 9 (23.1) |
| Surgical feasibility, n (%) | |
| Good | 36 (92.3) |
| Moderately difficult | 3 (7.7) |
| Blood loss, mL, mean (sd) | 182 (61.6) |
| Post‐sRP hospitalisation, days, mean (sd) | 1.9 (0.8) |
| pT Stage, n (%) | |
| pT2a/b | 6 (15.4) |
| pT2c | 15 (38.5) |
| pT3a | 15 (38.5) |
| pT3b | 3 (7.7) |
| ISUP GG, n (%) | |
| 1 | 2 (5.1) |
| 2 | 21 (53.8) |
| 3 | 8 (20.5) |
| 4 | 4 (10.3) |
| 5 | 4 (10.3) |
| PSM rate, n (%) | 10 (25.6) |
| Lymph node involvement, n (%) | 0 (0) |
| Location of recurrence, n (%) | |
| In‐field only | 7 (18.0) |
| Out‐of‐field only | 16 (41.0) |
| In‐field and out‐of‐field | 16 (41.0) |
| Follow‐up duration, months, median (IQR) | 17.7 (11.8–26.4) |